BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 22613355)

  • 1. Altered cofactor binding affects stability and activity of human UDP-galactose 4'-epimerase: implications for type III galactosemia.
    McCorvie TJ; Liu Y; Frazer A; Gleason TJ; Fridovich-Keil JL; Timson DJ
    Biochim Biophys Acta; 2012 Oct; 1822(10):1516-26. PubMed ID: 22613355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of two mutations associated with epimerase-deficiency galactosemia, by use of a yeast expression system for human UDP-galactose-4-epimerase.
    Quimby BB; Alano A; Almashanu S; DeSandro AM; Cowan TM; Fridovich-Keil JL
    Am J Hum Genet; 1997 Sep; 61(3):590-8. PubMed ID: 9326324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico prediction of the effects of mutations in the human UDP-galactose 4'-epimerase gene: towards a predictive framework for type III galactosemia.
    McCorvie TJ; Timson DJ
    Gene; 2013 Jul; 524(2):95-104. PubMed ID: 23644136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and characterization of a mutation, in the human UDP-galactose-4-epimerase gene, associated with generalized epimerase-deficiency galactosemia.
    Wohlers TM; Christacos NC; Harreman MT; Fridovich-Keil JL
    Am J Hum Genet; 1999 Feb; 64(2):462-70. PubMed ID: 9973283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of dynamics of wildtype and V94M human UDP-galactose 4-epimerase-A computational perspective on severe epimerase-deficiency galactosemia.
    Timson DJ; Lindert S
    Gene; 2013 Sep; 526(2):318-24. PubMed ID: 23732289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of function and substrate specificity in human UDP-galactose 4'-epimerase.
    Schulz JM; Watson AL; Sanders R; Ross KL; Thoden JB; Holden HM; Fridovich-Keil JL
    J Biol Chem; 2004 Jul; 279(31):32796-803. PubMed ID: 15175331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The metastability of human UDP-galactose 4'-epimerase (GALE) is increased by variants associated with type III galactosemia but decreased by substrate and cofactor binding.
    Pey AL; Padín-Gonzalez E; Mesa-Torres N; Timson DJ
    Arch Biochem Biophys; 2014 Nov; 562():103-14. PubMed ID: 25150110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of the V94M-substituted human UDPgalactose-4-epimerase enzyme associated with generalized epimerase-deficiency galactosaemia.
    Wohlers TM; Fridovich-Keil JL
    J Inherit Metab Dis; 2000 Nov; 23(7):713-29. PubMed ID: 11117433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo and in vitro function of human UDP-galactose 4'-epimerase variants.
    McCorvie TJ; Wasilenko J; Liu Y; Fridovich-Keil JL; Timson DJ
    Biochimie; 2011 Oct; 93(10):1747-54. PubMed ID: 21703329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional characterization of the K257R and G319E-hGALE alleles found in patients with ostensibly peripheral epimerase deficiency galactosemia.
    Wasilenko J; Lucas ME; Thoden JB; Holden HM; Fridovich-Keil JL
    Mol Genet Metab; 2005 Jan; 84(1):32-8. PubMed ID: 15639193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UDP-hexose 4-epimerases: a view on structure, mechanism and substrate specificity.
    Beerens K; Soetaert W; Desmet T
    Carbohydr Res; 2015 Sep; 414():8-14. PubMed ID: 26162744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mediators of galactose sensitivity in UDP-galactose 4'-epimerase-impaired mammalian cells.
    Schulz JM; Ross KL; Malmstrom K; Krieger M; Fridovich-Keil JL
    J Biol Chem; 2005 Apr; 280(14):13493-502. PubMed ID: 15701638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human UDP-galactose 4-epimerase. Accommodation of UDP-N-acetylglucosamine within the active site.
    Thoden JB; Wohlers TM; Fridovich-Keil JL; Holden HM
    J Biol Chem; 2001 May; 276(18):15131-6. PubMed ID: 11279032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular dynamics, residue network analysis, and cross-correlation matrix to characterize the deleterious missense mutations in GALE causing galactosemia III.
    Kumar SU; Sankar S; Kumar DT; Younes S; Younes N; Siva R; Doss CGP; Zayed H
    Cell Biochem Biophys; 2021 Jun; 79(2):201-219. PubMed ID: 33555556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changing the donor cofactor of bovine alpha 1, 3-galactosyltransferase by fusion with UDP-galactose 4-epimerase. More efficient biocatalysis for synthesis of alpha-Gal epitopes.
    Chen X; Liu Z; Wang J; Fang J; Fan H; Wang PG
    J Biol Chem; 2000 Oct; 275(41):31594-600. PubMed ID: 10913140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UDP-galactose 4' epimerase (GALE) is essential for development of Drosophila melanogaster.
    Sanders RD; Sefton JM; Moberg KH; Fridovich-Keil JL
    Dis Model Mech; 2010; 3(9-10):628-38. PubMed ID: 20519568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional analysis of disease-causing mutations in human UDP-galactose 4-epimerase.
    Timson DJ
    FEBS J; 2005 Dec; 272(23):6170-7. PubMed ID: 16302980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UDP-galactose 4'-epimerase activities toward UDP-Gal and UDP-GalNAc play different roles in the development of Drosophila melanogaster.
    Daenzer JM; Sanders RD; Hang D; Fridovich-Keil JL
    PLoS Genet; 2012; 8(5):e1002721. PubMed ID: 22654673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of UDP-galactose 4'-epimerase mutations associated with the intermediate form of type III galactosaemia.
    Chhay JS; Vargas CA; McCorvie TJ; Fridovich-Keil JL; Timson DJ
    J Inherit Metab Dis; 2008 Feb; 31(1):108-16. PubMed ID: 18188677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular basis for severe epimerase deficiency galactosemia. X-ray structure of the human V94m-substituted UDP-galactose 4-epimerase.
    Thoden JB; Wohlers TM; Fridovich-Keil JL; Holden HM
    J Biol Chem; 2001 Jun; 276(23):20617-23. PubMed ID: 11279193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.